ESTRO 2024 - Abstract Book

S1338

Clinical - Head & neck

ESTRO 2024

[4] Kachhwaha A, Jakhar S, Syiem T, Sharma N, Kumar H, Sharma A. Hypofractionated radiotherapy versus conventional radiotherapy in early glottic cancer T1-2N0M0: A randomized study. J Cancer Res Ther. 2021;17(6):1499. doi:10.4103/jcrt.jcrt_867_19 [5] Moon SH, Cho KH, Chung EJ, Lee CG, Lee KC, Chai GY, et al. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: Results of a Korean Radiation Oncology Group (KROG-0201) study. Radiotherapy and Oncology. 2014;110(1):98-103. doi:10.1016/j.radonc.2013.09.016

[6] Yu E, Shenouda G, Ch B, Beaudet MP, Black MJ. IMPACT OF RADIATION THERAPY FRACTION SIZE ON LOCAL CONTROL OF EARLY GLOTTIC CARCINOMA. Vol 37. Elsevier Science Inc; 1997.

[7] Kovarik J, Kelly C, Cunnell M, Jamil F, Iqbal MS. Hypofractionated (2.75 Gy per fraction) versus Conventionally Fractionated Primary Radiotherapy for T2N0M0 Carcinoma of the Glottis. Int Arch Otorhinolaryngol. 2023;27(01):e16-e23. doi:10.1055/s-0042-1745855 [8] Hussain R, Jamshed S, Majeed U, Hameed S, Jamshed A, Rehman KU, et al. Hypofractionated Radiotherapy in the Treatment of Early Glottic Carcinoma. Int J Head Neck Surg. 2011;2(3):138-143. doi:10.5005/jp-journals-10001 1069

[9] Dixon LM, Douglas CM, Shaukat SI, Garcez K, Lee LW, Sykes AJ, et al. Conventional fractionation should not be the standard of care for T2 glottic cancer. Radiation Oncology. 2017;12(1). doi:10.1186/s13014-017-0915-8

[10] De Santis RJ, Poon I, Lee J, Karam I, Enepekides DJ, Higgins KM. Comparison of survival between radiation therapy and trans-oral laser microsurgery for early glottic cancer patients; A retrospective cohort study. Journal of Otolaryngology - Head and Neck Surgery. 2016;45(1). doi:10.1186/s40463-016-0155-1 [11] de Ridder M, Rijken JA, Smits HJG, Smid EJ, Doornaert PAH, de Bree R. Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 2023;280(7):3345-3352. doi:10.1007/s00405-023-07904-2

1803

Digital Poster

Mapping the research landscape of HPV-positive oropharyngeal cancer: a bibliometric analysis

Federico Mastroleo 1,2 , Angela Ammirabile 3,4 , Caterina Giannitto 3,4 , Daniela Alterio 1 , Ciro Franzese 5,4 , Marta Scorsetti 5,4 , Pierfrancesco Franco 2 , Giulia Marvaso 1,6 , Barbara Alicja Jereczek 1,6 1 IEO European Institute of Oncology IRCCS, Division of Radiation Oncology, Milan, Italy. 2 University of Piemonte Orientale, Department of Translational Medicine, Novara, Italy. 3 Humanitas Research Hospital, Department of Diagnostic and Interventional Radiology, Rozzano, Italy. 4 Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, Italy. 5 Humanitas Research Hospital, Radiotherapy and Radiosurgery Department, Rozzano, Italy. 6 University of Milan, Department of Oncology and Hemato-Oncology, Milan, Italy